Down's syndrome results from the production of three copies of chromos
ome 21 within a cell. We have devised a method termed the homologous g
ene quantitative polymerase chain reaction (HGQ-PCR), which uses one p
air of primers and which can directly identify the additional copy of
chromosome 21 by simultaneously amplifying two highly homologous genes
of the human liver-type phosphofructokinase located on chromosome 21
(PFKL-CH21) and the human muscle-type phosphofructokinase located on c
hromosome 1 (PFKM-CH1) for self-detecting determination. On analysis o
f 34 cases of Down's syndrome, including two cases of unbalanced trans
location 46, XY, der (14; 21) (q10; q10), +21, and 100 normal individu
als, the relative ratio of the PFKM-CH1/PFKL-CH21 product was 1.33 +/-
0.323 (mean +/- SD) and 0.40 +/- 0.16 (mean +/- SD) for disomy DNA an
d trisomy DNA, respectively. The difference between these two groups w
as highly significant (P < 0.001). These results indicate that this qu
antitative method is practical and may be used for the prenatal diagno
sis of Down's syndrome caused by trisomy 21.